The history of aspirin [1]

Texas Heart Institute Journal

Volumn 34, Issue 3, 2007, Pages 392-

  Folts, John D ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; HEPARIN; FIBRINOLYTIC AGENT;

ANGINA PECTORIS; CIGARETTE SMOKING; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY THROMBOSIS; DISEASE EXACERBATION; HUMAN; LETTER; NONHUMAN; PERIPHERAL VASCULAR DISEASE; THROMBOEMBOLISM; VASOSPASM; ANIMAL; DISEASE MODEL; DRUG EFFECT; HISTORY; NOTE; PATHOPHYSIOLOGY; PHYSIOLOGY;

ANIMALS; ASPIRIN; CORONARY CIRCULATION; CORONARY THROMBOSIS; DISEASE MODELS, ANIMAL; FIBRINOLYTIC AGENTS; HISTORY, 20TH CENTURY; HUMANS;

EID: 35848946563     PISSN: 07302347     EISSN: 15266702     Source Type: Journal    
DOI: None     Document Type: Letter

References (5)

1. Miner J, Hoffhines A. The discovery of aspirin's antithrombotic effects. Tex Heart Inst J 2007;34:179-86.
2. Folts JD, Crowell EB, Rowe GG. Platelet aggregation in partially obstructed coronary arteries and their inhibition with aspirin. Clin Res 1974;22:595A.
3. Folts JD, Crowell EB, Rowe GG. Platelet aggregation in partially obstructed vessels and its elimination with aspirin. Circulation 1976;54:365-70.
4. Folts JD, Detmer DE, Nadler R. Possible platelet thrombi formation in dog and human femoral arteries. Tex Heart Inst J 1982;9:19-26.
5. Folts JD, Schafer AI, Loscalzo J, Willerson JT, Mueller JE. A perspective on the potential problems with aspirin as an antithrombotic agent: a comparison of studies in an animal model with clinical trials. J Am Coll Cardiol 1999;33:295-303.